| Product Code: ETC5359009 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The import shipments of buprenorphine into Guatemala in 2024 continued to be dominated by top exporting countries such as China, Germany, India, Hong Kong, and Spain. Despite a high concentration level indicated by a high Herfindahl-Hirschman Index (HHI), the compound annual growth rate (CAGR) from 2020 to 2024 experienced a decline of -10.89%. Additionally, the growth rate in 2024 saw a significant decrease of -28.59% compared to the previous year, reflecting a challenging environment for buprenorphine imports into Guatemala.

By 2027, the Buprenorphine market in Guatemala is anticipated to reach a growth rate of 5.16%, as part of an increasingly competitive Latin America region, where Brazil remains at the forefront, supported by Mexico, Argentina, Colombia and Chile, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guatemala Buprenorphine Market Overview |
3.1 Guatemala Country Macro Economic Indicators |
3.2 Guatemala Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Guatemala Buprenorphine Market - Industry Life Cycle |
3.4 Guatemala Buprenorphine Market - Porter's Five Forces |
3.5 Guatemala Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Guatemala Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Guatemala Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Guatemala Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of buprenorphine therapy in Guatemala |
4.2.2 Rising prevalence of opioid addiction and the need for effective treatment options |
4.2.3 Government initiatives promoting the use of buprenorphine in addiction treatment programs |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas, impacting the reach of buprenorphine treatment |
4.3.2 Stigma associated with medication-assisted treatment for opioid addiction |
4.3.3 High cost of buprenorphine treatment for patients without insurance coverage |
5 Guatemala Buprenorphine Market Trends |
6 Guatemala Buprenorphine Market Segmentations |
6.1 Guatemala Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Guatemala Buprenorphine Market Revenues & Volume, By Analgesic, 2021-2031F |
6.1.3 Guatemala Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2021-2031F |
6.2 Guatemala Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Guatemala Buprenorphine Market Revenues & Volume, By Injectables, 2021-2031F |
6.2.3 Guatemala Buprenorphine Market Revenues & Volume, By Sublingual, 2021-2031F |
6.2.4 Guatemala Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2021-2031F |
6.3 Guatemala Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Guatemala Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Guatemala Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Guatemala Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Guatemala Buprenorphine Market Import-Export Trade Statistics |
7.1 Guatemala Buprenorphine Market Export to Major Countries |
7.2 Guatemala Buprenorphine Market Imports from Major Countries |
8 Guatemala Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare facilities offering buprenorphine treatment in Guatemala |
8.2 Percentage of opioid addiction patients receiving buprenorphine therapy |
8.3 Rate of successful treatment outcomes with buprenorphine therapy |
9 Guatemala Buprenorphine Market - Opportunity Assessment |
9.1 Guatemala Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Guatemala Buprenorphine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Guatemala Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Guatemala Buprenorphine Market - Competitive Landscape |
10.1 Guatemala Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Guatemala Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here